Quality-by-Design (QbD): An integrated multivariate approach for the component quantification in powder blends

被引:75
作者
Wu, Huiquan [1 ]
Tawakkul, Mobin [1 ]
White, Maury [1 ]
Khan, Mansoor A. [1 ]
机构
[1] OTR OPS CDER FDA, DPQR, HFD 940, Silver Spring, MD 20993 USA
关键词
Quality-by-Design (QbD); Process analytical technology (PAT); Design of experiments; Multivariate statistical data analysis; Powder blending; Component quantification; Moving block standard deviation; ANOVA; Scale of scrutiny; Modeling; NEAR-INFRARED SPECTROSCOPY; PROCESS ANALYTICAL TECHNOLOGY; AUTOMATED-SYSTEM; REAL-TIME; HOMOGENEITY; SIZE;
D O I
10.1016/j.ijpharm.2009.01.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this study was to develop an integrated multivariate approach to quantify the constituent concentrations of both drug and excipients of powder blends. A mixture design was created to include 26 powder formulations consisting of ibuprofen as the model drug and three excipients (HPMC, MCC, and Eudragit L100-55). The mixer was stopped at various time points to enable near-infrared (NIR) scan of the powder mixture and sampling for UV assay. Partial least square (PLS), principal component regression (PCR), and multiple linear regression (MLR) models were established to link the formulation concentrations with the Savitzky-Golay 1st derivative NIR spectral data at various characteristic wavelengths of each component. PLS models based on the NIR data and UV data were calibrated and validated. They predicted the main components' concentrations well in the powder blends, although prediction errors were larger for minor components. As expected from the complete random-mixture (CRM) model, the measurement uncertainties were higher for minor components in the powder formulations. The prediction performance differences between the NIR model and UV model were explained in the context of scale of scrutiny and model applicability. The importance of understanding excipient variability in powder blending and its implication for blending homogeneity assessment is highlighted. Published by Elsevier B.V.
引用
收藏
页码:39 / 48
页数:10
相关论文
共 27 条
[1]   USE OF A LIGHT PROBE FOR ASSESSING HOMOGENEITY OF POWDER MIXTURES [J].
ASHTON, MD ;
SCHOFIEL.C ;
VALENTIN, FH .
CHEMICAL ENGINEERING SCIENCE, 1966, 21 (10) :843-&
[2]   Examination of homogeneity with X-ray beams [J].
Beretzky, A ;
Joo, K ;
Eros, I ;
Pintye-Hódi, K .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 291 (1-2) :155-159
[3]   Effective sample size in diffuse reflectance near-IR spectrometry [J].
Berntsson, O ;
Burger, T ;
Folestad, S ;
Danielsson, LG ;
Kuhn, J ;
Fricke, J .
ANALYTICAL CHEMISTRY, 1999, 71 (03) :617-623
[4]   Effective mass sampled by NIR fiber-optic reflectance probes in blending processes [J].
Cho, J ;
Gemperline, PJ ;
Aldridge, PK ;
Sekulic, SS .
ANALYTICA CHIMICA ACTA, 1997, 348 (1-3) :303-310
[5]   Near-infrared spectroscopy and imaging for the monitoring of powder blend homogeneity [J].
El-Hagrasy, AS ;
Morris, HR ;
D'Amico, F ;
Lodder, RA ;
Drennen, JK .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (09) :1298-1307
[6]  
fda, GUID IND PAT FRAM IN
[7]  
FDA Draft Guidance for Industry, 2003, GUID IND PO IN PRESS
[8]  
FDA/ICH, 2006, GUID IND Q8 PHARM DE
[9]  
FDA/ICH Guidance for Industry, 2006, GUID IND Q9 QUAL RIS
[10]  
Food and Drug Administration (FDA), PHARM CGMPS 21 CENT